NYSE:NUS Nu Skin Enterprises (NUS) Stock Price, News & Analysis $7.49 -0.10 (-1.32%) (As of 11/20/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends About Nu Skin Enterprises Stock (NYSE:NUS) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Nu Skin Enterprises alerts:Sign Up Key Stats Today's Range$7.34▼$7.7150-Day Range$6.07▼$7.8152-Week Range$5.95▼$20.75Volume810,722 shsAverage Volume832,076 shsMarket Capitalization$372.33 millionP/E RatioN/ADividend Yield3.20%Price Target$8.88Consensus RatingHold Company OverviewNu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products. The company also provides wellness products, such as LifePak nutritional supplements, ageLOC TR90 weight management system, and Beauty Focus Collagen+. In addition, it is involved in the research and product development of skin care products and nutritional supplements. The company sells its products under the Nu Skin, Pharmanex, and ageLOC brands through retail stores, website, digital platforms, and independent direct sellers and marketers, as well as a service center. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.Read More… Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…Claim your FREE 2024 Gold Guide Nu Skin Enterprises Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks74th Percentile Overall ScoreNUS MarketRank™: Nu Skin Enterprises scored higher than 74% of companies evaluated by MarketBeat, and ranked 54th out of 139 stocks in the consumer staples sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.0 / 5Analyst RatingHold Consensus RatingNu Skin Enterprises has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 2 hold ratings, and no sell ratings.Amount of Analyst CoverageNu Skin Enterprises has only been the subject of 1 research reports in the past 90 days.Read more about Nu Skin Enterprises' stock forecast and price target. Earnings and Valuation2.5 / 5Proj. Earnings Growth36.11% Earnings GrowthEarnings for Nu Skin Enterprises are expected to grow by 36.11% in the coming year, from $0.72 to $0.98 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Nu Skin Enterprises is -3.62, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Nu Skin Enterprises is -3.62, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioNu Skin Enterprises has a P/B Ratio of 0.53. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Nu Skin Enterprises' valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted3.21% of the float of Nu Skin Enterprises has been sold short.Short Interest Ratio / Days to CoverNu Skin Enterprises has a short interest ratio ("days to cover") of 1.4, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Nu Skin Enterprises has recently increased by 3.31%, indicating that investor sentiment is decreasing. Dividend1.7 / 5Dividend StrengthWeak Dividend YieldNu Skin Enterprises pays a meaningful dividend of 3.16%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthNu Skin Enterprises does not have a long track record of dividend growth.Dividend SustainabilityBased on earnings estimates, Nu Skin Enterprises will have a dividend payout ratio of 24.49% next year. This indicates that Nu Skin Enterprises will be able to sustain or increase its dividend.Read more about Nu Skin Enterprises' dividend. Sustainability and ESG1.4 / 5Environmental Score-2.56 Percentage of Shares Shorted3.21% of the float of Nu Skin Enterprises has been sold short.Short Interest Ratio / Days to CoverNu Skin Enterprises has a short interest ratio ("days to cover") of 1.4, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Nu Skin Enterprises has recently increased by 3.31%, indicating that investor sentiment is decreasing. News and Social Media1.1 / 5News SentimentN/A Search Interest14 people have searched for NUS on MarketBeat in the last 30 days. This is an increase of 600% compared to the previous 30 days.MarketBeat Follows3 people have added Nu Skin Enterprises to their MarketBeat watchlist in the last 30 days. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Nu Skin Enterprises insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 1.70% of the stock of Nu Skin Enterprises is held by insiders.Percentage Held by Institutions82.84% of the stock of Nu Skin Enterprises is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Nu Skin Enterprises' insider trading history. Receive NUS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nu Skin Enterprises and its competitors with MarketBeat's FREE daily newsletter. Email Address NUS Stock News HeadlinesNu Skin lays off more employees amid financial woesNovember 13, 2024 | msn.comNu Skin (NYSE:NUS) Reports Sales Below Analyst Estimates In Q3 EarningsNovember 12, 2024 | theglobeandmail.comBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…November 21, 2024 | Crypto 101 Media (Ad)Nu Skin (NYSE:NUS) Reports Sales Below Analyst Estimates In Q3 EarningsNovember 12, 2024 | theglobeandmail.comNu Skin: New Products And Ongoing Digital Transformation Imply UndervaluationNovember 12, 2024 | seekingalpha.comNu Skin Enterprises Inc (NUS) Q3 2024 Earnings Call Highlights: Navigating Challenges with ...November 8, 2024 | finance.yahoo.comQ3 2024 NU Skin Enterprises Inc Earnings Call TranscriptNovember 8, 2024 | gurufocus.comNu Skin Enterprises, Inc. (NUS) Q3 2024 Earnings Call TranscriptNovember 7, 2024 | seekingalpha.comSee More Headlines NUS Stock Analysis - Frequently Asked Questions How have NUS shares performed this year? Nu Skin Enterprises' stock was trading at $19.42 at the start of the year. Since then, NUS shares have decreased by 61.4% and is now trading at $7.49. View the best growth stocks for 2024 here. How were Nu Skin Enterprises' earnings last quarter? Nu Skin Enterprises, Inc. (NYSE:NUS) announced its quarterly earnings results on Thursday, August, 8th. The company reported $0.21 earnings per share for the quarter, topping analysts' consensus estimates of $0.17 by $0.04. The business's revenue was down 12.2% on a year-over-year basis. Who are Nu Skin Enterprises' major shareholders? Top institutional shareholders of Nu Skin Enterprises include State Street Corp (2.51%), Geode Capital Management LLC (2.27%), Jane Street Group LLC (1.86%) and Charles Schwab Investment Management Inc. (1.83%). Insiders that own company stock include Ryan S Napierski, Steven Keith Hatchett, Mark H Lawrence, Andrew D Lipman, Joseph Y Chang, Steven Lund, Edwina D Woodbury, James D Thomas, Laura Nathanson and Emma S Battle. View institutional ownership trends. How do I buy shares of Nu Skin Enterprises? Shares of NUS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Nu Skin Enterprises own? Based on aggregate information from My MarketBeat watchlists, some other companies that Nu Skin Enterprises investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), Netflix (NFLX), Alphabet (GOOG) and Intel (INTC). Company Calendar Last Earnings8/08/2024Ex-Dividend for 9/11 Dividend8/30/2024Dividend Payable9/11/2024Today11/21/2024Ex-Dividend for 12/11 Dividend11/29/2024Dividend Payable12/11/2024Fiscal Year End12/31/2024Next Earnings (Estimated)2/12/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorConsumer Staples Industry Drugs, proprietaries, & sundries Sub-IndustryPersonal Products Current SymbolNYSE:NUS CUSIP67018T10 CIK1021561 Webwww.nuskinenterprises.com Phone(801) 345-1000Fax801-345-5999Employees3,700Year FoundedN/APrice Target and Rating Average Stock Price Target$8.88 High Stock Price Target$11.00 Low Stock Price Target$6.75 Potential Upside/Downside+18.5%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($2.07) Trailing P/E RatioN/A Forward P/E Ratio10.40 P/E GrowthN/ANet Income$8.60 million Net Margins-5.81% Pretax Margin-6.08% Return on Equity5.47% Return on Assets2.46% Debt Debt-to-Equity Ratio0.53 Current Ratio1.93 Quick Ratio1.20 Sales & Book Value Annual Sales$1.78 billion Price / Sales0.21 Cash Flow$3.26 per share Price / Cash Flow2.30 Book Value$16.60 per share Price / Book0.45Miscellaneous Outstanding Shares49,711,000Free Float48,866,000Market Cap$372.34 million OptionableOptionable Beta1.14 Social Links The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report This page (NYSE:NUS) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nu Skin Enterprises, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nu Skin Enterprises With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.